Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities Growth (1y) (2012 - 2025)
Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities Growth (1y) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Catalyst Pharmaceuticals |
3.84 Bn |
3.08 Bn |
134.92 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
63.64% |
| Jun 30, 2025 |
-160.00% |
| Dec 31, 2024 |
99.77% |
| Sep 30, 2024 |
99.72% |
| Mar 31, 2024 |
99.88% |
| Sep 30, 2023 |
-70,215.91% |
| Sep 30, 2022 |
-94.12% |
| Sep 30, 2021 |
99.32% |
| Mar 31, 2021 |
-238.22% |
| Sep 30, 2020 |
-298.35% |
| Mar 31, 2020 |
-52.15% |
| Dec 31, 2019 |
123.85% |
| Sep 30, 2019 |
-33.39% |
| Jun 30, 2019 |
-100.41% |
| Mar 31, 2019 |
132.81% |
| Dec 31, 2018 |
23,165.63% |
| Sep 30, 2018 |
25,492.94% |
| Jun 30, 2018 |
-280,642.10% |
| Mar 31, 2018 |
-95,985.96% |
| Dec 31, 2017 |
-89.63% |
